Cite
Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy
MLA
Soroush Moallef, et al. “Inability to Contact Opioid Agonist Therapy Prescribers during the COVID-19 Pandemic in a Canadian Setting: A Cross-Sectional Analysis among People on Opioid Agonist Therapy.” Addiction Science & Clinical Practice, vol. 17, no. 1, Dec. 2022, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s13722-022-00354-x.
APA
Soroush Moallef, Kora DeBeck, Nadia Fairbairn, Zishan Cui, Rupinder Brar, Dean Wilson, Cheyenne Johnson, M.-J. Milloy, & Kanna Hayashi. (2022). Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy. Addiction Science & Clinical Practice, 17(1), 1–9. https://doi.org/10.1186/s13722-022-00354-x
Chicago
Soroush Moallef, Kora DeBeck, Nadia Fairbairn, Zishan Cui, Rupinder Brar, Dean Wilson, Cheyenne Johnson, M.-J. Milloy, and Kanna Hayashi. 2022. “Inability to Contact Opioid Agonist Therapy Prescribers during the COVID-19 Pandemic in a Canadian Setting: A Cross-Sectional Analysis among People on Opioid Agonist Therapy.” Addiction Science & Clinical Practice 17 (1): 1–9. doi:10.1186/s13722-022-00354-x.